Patrick Treanor - May 26, 2022 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
May 26, 2022
Transactions value $
$0
Form type
4
Date filed
5/27/2022, 04:18 PM
Next filing
Sep 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Stock Option (right to buy) Award $0 +17K $0.00 17K May 26, 2022 Common Stock 17K $8.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a 36 month period: 1/36th on June 26, 2022, after which 1/36th of the total shares vest monthly, subject to the Reporting Person's continued service through each vesting date.